Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma - PubMed (original) (raw)
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
N L Smith et al. Eur Respir J. 2011 Apr.
Free article
Abstract
Chronic pulmonary aspergillosis (CPA) is a condition caused by the ubiquitous fungus Aspergillus fumigatus in non-immunocompromised individuals. Numerous underlying conditions have been associated with CPA. Details of the underlying conditions of 126 CPA patients attending our tertiary referral clinic from all over the UK were extracted from the clinical notes, and the distribution of these underlying conditions was analysed. For those with several underlying pulmonary conditions, one was nominated as the primary condition. Many patients presented with multiple underlying conditions, and a total of 232 underlying conditions were identified for the 126 patients. Previous classical tuberculosis and non-tuberculous mycobacterial infection were the most common primary underlying conditions (15.3% and 14.9%, respectively). Others included allergic bronchopulmonary aspergillosis (ABPA), chronic obstructive pulmonary condition (COPD) and/or emphysema, pneumothorax and prior treated lung cancer. Some conditions were found more often as one of multiple underlying conditions, while others were found only as secondary underlying conditions. Tuberculosis, non-tuberculous mycobacterial infection and ABPA remain the predominant risk factors for development of CPA, with COPD, prior pneumothorax or treated lung cancer also relatively common among our referrals. Many patients have multiple underlying pulmonary conditions. CPA should be considered when upper lobe cavitary or fibrotic disease and systemic symptoms are present in those with lung disease.
Similar articles
- [Expert consensus on the diagnosis and treatment of pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].
Chinese Thoracic Society of Chinese Medical Association. Chinese Thoracic Society of Chinese Medical Association. Zhonghua Jie He He Hu Xi Za Zhi. 2024 Jul 12;47(7):604-622. doi: 10.3760/cma.j.cn112147-20231228-00399. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38955746 Chinese. - Noninvasive pulmonary Aspergillus infections.
Riscili BP, Wood KL. Riscili BP, et al. Clin Chest Med. 2009 Jun;30(2):315-35, vii. doi: 10.1016/j.ccm.2009.02.008. Clin Chest Med. 2009. PMID: 19375638 Review. - The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K, Sands D. Walicka-Serzysko K, et al. Dev Period Med. 2015 Jan-Mar;19(1):66-79. Dev Period Med. 2015. PMID: 26003072 - [Chronic pulmonary aspergillosis].
Tsuji S, Ogawa K. Tsuji S, et al. Nihon Rinsho. 2011 Aug;69(8):1462-7. Nihon Rinsho. 2011. PMID: 21838048 Review. Japanese. - [Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].
Ehret N, Carlier N, Marey J, Rabbat A, Burgel PR, Roche N. Ehret N, et al. Rev Mal Respir. 2020 Apr;37(4):308-319. doi: 10.1016/j.rmr.2020.02.011. Epub 2020 Apr 10. Rev Mal Respir. 2020. PMID: 32284206 French.
Cited by
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE. Patterson TF, et al. Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29. Clin Infect Dis. 2016. PMID: 27365388 Free PMC article. - Primary pulmonary leiomyosarcoma with coexistent pulmonary aspergillosis: a case report.
Badheeb A, Al Gharem N, Al Hammadi S, Elsagheer S, Badheeb M, Ahmed F. Badheeb A, et al. Pan Afr Med J. 2022 Jun 20;42:135. doi: 10.11604/pamj.2022.42.135.34116. eCollection 2022. Pan Afr Med J. 2022. PMID: 36060845 Free PMC article. - A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis.
Adetiloye AO, Alladin F, Alaameri R, Valencia-Manrique JC, Badero O, Poor A. Adetiloye AO, et al. Am J Case Rep. 2023 Mar 16;24:e938359. doi: 10.12659/AJCR.938359. Am J Case Rep. 2023. PMID: 36927852 Free PMC article. - Concomitant occurrence of advanced fibrocavitary pulmonary sarcoidosis and chronic pulmonary aspergillosis.
Khor SY, Gullapalli K, Sharma A, Garces CC. Khor SY, et al. BMJ Case Rep. 2022 Aug 22;15(8):e250751. doi: 10.1136/bcr-2022-250751. BMJ Case Rep. 2022. PMID: 35995460 Free PMC article. - Case Report: Chronic Pulmonary Aspergillosis-An Unusual Long-Term Complication of Lung Cancer Treatment.
Guziejko K, Klukowska K, Budzińska U, Mróz RM. Guziejko K, et al. Front Med (Lausanne). 2022 Jan 12;8:777457. doi: 10.3389/fmed.2021.777457. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35096873 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical